» Articles » PMID: 29163698

Cytokeratin 17 MRNA As a Prognostic Marker of Oral Squamous Cell Carcinoma

Overview
Journal Oncol Lett
Specialty Oncology
Date 2017 Nov 23
PMID 29163698
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Despite diagnostic and therapeutic advances, the 5-year survival rate of oral squamous cell carcinoma (OSCC) remains between 70-80% due to recurrences and secondary metastases to cervical lymph nodes. It is difficult to find these recurrences and metastases postoperatively, thus, careful follow-up is recommended. Cytokeratins (CKs) are intermediate filaments of the cytoskeleton and candidate prognostic biomarkers for OSCC, as they are overexpressed in OSCC compared with normal mucosa. The aim of the present study was to determine the relative levels of occurrence of 3 CK mRNA (CK17, CK19, CK20) transcripts in peripheral blood mononuclear cells (PBMC) using reverse transcription-quantitative polymerase chain reaction. The study comprised pre- and post-operative PBMC samples from 19 OSCC patients. In the good-prognosis group, 10 of 13 patients demonstrated reduced CK17 mRNA expression post-operatively, compared with pre-operative samples, conversely, only 3 of 6 patients in the poor-prognosis group had reduced post-operative CK17 mRNA expression. This difference was statistically significant (P<0.01). The disease-free survival rate of the group with reduced post-operative CK17 mRNA expression was significantly increased compared with the elevated CK17 mRNA group (P<0.01); however, the overall survival rates of the two groups were not significantly different. Neither CK19 mRNA nor CK20 mRNA were significantly expressed in the PBMC of OSCC patients. Overall, CK17 mRNA expression may be a useful prognostic biomarker for OSCC.

Citing Articles

Emerging Prognostic and Predictive Significance of Stress Keratin 17 in HPV-Associated and Non HPV-Associated Human Cancers: A Scoping Review.

Lozar T, Wang W, Gavrielatou N, Christensen L, Lambert P, Harari P Viruses. 2023; 15(12).

PMID: 38140561 PMC: 10748233. DOI: 10.3390/v15122320.


Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and Beyond.

Lozar T, Laklouk I, Golfinos A, Gavrielatou N, Xu J, Flynn C Cancers (Basel). 2023; 15(19).

PMID: 37835599 PMC: 10571921. DOI: 10.3390/cancers15194905.


Tumor matrix stiffness provides fertile soil for cancer stem cells.

Safaei S, Sajed R, Shariftabrizi A, Dorafshan S, Saeednejad Zanjani L, Manshadi M Cancer Cell Int. 2023; 23(1):143.

PMID: 37468874 PMC: 10357884. DOI: 10.1186/s12935-023-02992-w.


The Role of Keratin17 in Human Tumours.

Zhang H, Zhang Y, Xia T, Lu L, Luo M, Chen Y Front Cell Dev Biol. 2022; 10:818416.

PMID: 35281081 PMC: 8912659. DOI: 10.3389/fcell.2022.818416.


Diagnostic Value of Cytokeratin 17 during Oral Carcinogenesis: An Immunohistochemical Study.

Sanguansin S, Kosanwat T, Juengsomjit R, Poomsawat S Int J Dent. 2021; 2021:4089549.

PMID: 34853592 PMC: 8629611. DOI: 10.1155/2021/4089549.

References
1.
Davelaar E, van de Lande J, von Mensdorff-Pouilly S, Blankenstein M, Verheijen R, Kenemans P . A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer. Tumour Biol. 2008; 29(1):9-17. DOI: 10.1159/000132566. View

2.
Burchill S, Bradbury M, Pittman K, Southgate J, Smith B, Selby P . Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer. 1995; 71(2):278-81. PMC: 2033587. DOI: 10.1038/bjc.1995.56. View

3.
Benoy I, Elst H, Philips M, Wuyts H, van Dam P, Scharpe S . Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer. Br J Cancer. 2006; 94(5):672-80. PMC: 2361203. DOI: 10.1038/sj.bjc.6602985. View

4.
Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

5.
Jung R, Kruger W, Hosch S, Holweg M, Kroger N, Gutensohn K . Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. Br J Cancer. 1998; 78(9):1194-8. PMC: 2063007. DOI: 10.1038/bjc.1998.653. View